Ryffel B, Brockhaus M, Greiner B, Mihatsch M J, Gudat F
University of Basel, Department of Pathology, Switzerland.
Immunology. 1991 Nov;74(3):446-52.
The nature and location of cells responding to tumour necrosis factor-alpha (TNF-alpha) were investigated in situ by immunohistochemistry using monoclonal antibodies (mAb) directed against the p75 and p55 proteins of the TNF receptor. Receptor expression was found in the thymus and secondary lymphoid tissues. In the thymus the p75 receptor was confined to medullary lymphoblasts and dendritic cells, which co-stain with the Tac protein of the interleukin-2 (IL-2) receptor. In lymph nodes and other secondary lymphoid tissues, the p75 receptor was expressed on activated lymphocytes and interdigitating reticulum cells of the T-cell area, whereas the p55 receptor was confined to the germinal centre dendritic reticulum cells (DRC), which is the main site of TNF-alpha production. TNF receptor (TNFR) proteins were up-regulated in reactive hyperplasia together with increased TNF-alpha expression. Surprisingly, no TNFR was detectable on non-lymphoid tissues. The species specificity of these TNFR antibodies was high: whereas the antibodies cross-reacted with epitopes in non-human primates, no immunoreactivity was detected in lower animal species, e.g. dog, rabbit and rodents. The data presented suggest that TNF-alpha, which is produced by germinal centre DRC, might regulate an in vivo immune response through autocrine and paracrine pathways, e.g. through the p55 and p75 receptor proteins, which are expressed at different sites of the lymphoid tissue.
使用针对肿瘤坏死因子-α(TNF-α)受体的p75和p55蛋白的单克隆抗体(mAb),通过免疫组织化学原位研究了对TNF-α作出反应的细胞的性质和位置。在胸腺和二级淋巴组织中发现了受体表达。在胸腺中,p75受体局限于髓质成淋巴细胞和树突状细胞,它们与白细胞介素-2(IL-2)受体的Tac蛋白共染色。在淋巴结和其他二级淋巴组织中,p75受体在活化的淋巴细胞和T细胞区的交错网状细胞上表达,而p55受体局限于生发中心树突状网状细胞(DRC),这是TNF-α产生的主要部位。在反应性增生中,TNF受体(TNFR)蛋白与TNF-α表达增加一起上调。令人惊讶的是,在非淋巴组织上未检测到TNFR。这些TNFR抗体的物种特异性很高:虽然这些抗体与非人类灵长类动物的表位发生交叉反应,但在较低等动物物种如狗、兔子和啮齿动物中未检测到免疫反应性。所呈现的数据表明,由生发中心DRC产生的TNF-α可能通过自分泌和旁分泌途径调节体内免疫反应,例如通过在淋巴组织不同部位表达的p55和p75受体蛋白。